Other
Arthroscopic Shoulder Surgery
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Arthroscopic Shoulder Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are Capstone Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
17
clinical trials
Completed13 · 76%
Unknown status1 · 6%
Terminated1 · 6%
Recruiting1 · 6%
Not yet recruiting1 · 6%
Clinical Trials
Trial Activity
17 trials
Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery
Completed·NNorth American Institute for Continuing Medical Education (NAICE)·N/A·NCT02554357·50 enrolled
Onset and Recovery of Ultrasound Guided Out-of-plane Versus In-plane Interscalene Block in Arthroscopic Shoulder Surgery
Completed·—·N/A·NCT05381389·60 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)